Global Biopharmaceutical Company - Bristol Myers Squibb

What's the future of cell therapy at BMS?

Anne Kerber, senior vice president and head of late clinical development, discusses recent developments within BMS' cell therapy work and where the science is heading.

'Not broken, but reborn'

BMS employee-patient Rosario helps patients through her work and spreads hope through the 'healing pieces' she creates as an artist.

Global Patient Week 2023

Explore BMS

New FDA approval for ROS1+ lung cancer >

Our most recent approval offers a new targeted therapy for adults with ROS1+ non-small cell lung cancer, an aggressive disease that’s difficult to treat.

A researcher wearing a Bristol Myers Squibb lab coat and safety glasses uses her fingers to zoom in on a tablet screen.

What is BMS doing on the world stage to advance global health and access to innovation >

psoriasis patient in an outside environment

What is it like to live with psoriasis? >

Learn from real patients as they discuss the unique challenges they face.

Scientific Media Resources >

Our scientists are driven by curiosity to pursue the best outcomes possible for patients. Explore our strategic research approaches that allow us to investigate the potential of our early discoveries, no matter the platform or modality.